Clinical Trial Update: Gabapentin Premedication and Adenotonsillectomy in Pediatric Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating gabapentin given before adenotonsillectomy to reduce postoperative nausea and vomiting in pediatric patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Cairo University | Conditions: Post Operative Nausea and Vomiting (PONV), Adenotonsillectomy | Phase 3 | Status: COMPLETED